HopeStage
Back to overview

Anxiety studies

Topics
More filters

Anxiety

Anxiety conditions involve intense, persistent fears or worries that can interfere with everyday life.

5111studies shown
Showing 1,957-1,968 of 5,111
Drug study icon
CompletedEUCTR 2004-002577-23

Efficacy and safety of Agomelatine (25 mg with potential adjustment at 50 mg) given orally once a day for 12 weeks in out-patients with Generalised Anxiety Disorder. A randomised flexible dose doub...

This study has finished and is no longer accepting participants.

Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.

In Finland
AnxietyHistorical research record
Countries
Finland
Sponsor
Institut de Recherches Internationales Servier
Drug study icon
CompletedEUCTR 2012-003404-12

Pharmacokinetics and safety of agomelatine in children (from 7 to less than 12 years) and adolescents (from 12 to less than 18 years) with Depressive or Anxiety Disorder. An open-labelled, multice...

This study has finished and is no longer accepting participants.

Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.

In Estonia
Anxiety, DepressionHistorical research record
Countries
Estonia, Finland, Hungary, + 3 others
Sponsor
Institut de Recherches Internationales Servier
Drug study icon
CompletedNCT01751386

Baclofen for Treating Anxiety and Alcoholism

Official study title

A Double-Blind, Placebo-Controlled, Randomized Human Laboratory Pilot Study of Baclofen in Anxious Alcoholics

This study has finished and is no longer accepting participants.

In Bethesda
AnxietyMedication studyAges 21–65
Countries
United States
Sponsor
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Drug study icon
CompletedNCT03504475

Bioequivalence Study of Paroxetine Tablets and Paxil® Under Fasting and Fed Conditions in Chinese Healthy Volunteers

Official study title

An Open-Label Randomized, Single-Dose, 2-way Crossover Bioequivalence Study of Paroxetine Hydrochloride 20 mg Tablets and Paxil® Under Fasting Conditions and Under Fed Conditions in Chinese Healthy Volunteers

This study has finished and is no longer accepting participants.

Multiple locations, including Beijing
Anxiety, Depression, ...Medication studyAges 18–65
Countries
China
Sponsor
Beijing Tongren Hospital
Device study icon
CompletedNCT04950257

Evaluating the Effects of a Self-help Mobile Phone Application on Worry and Overthinking in Young Adults Aged Between 16 and 24.

Official study title

Evaluating the Effects of a Self-help Mobile Phone Application on Worry and Rumination Experienced by Young Adults: a Preventative Intervention for Depression and Anxiety

This study has finished and is no longer accepting participants.

In Exeter
AnxietyDevice studyAges 16–24
Countries
United Kingdom
Sponsor
University of Exeter
Behavioral study icon
CompletedNCT02045225

HIV Prevention for HIV-Negative Men Via Reduction of Social Anxiety

Official study title

An HIV Prevention Intervention for HIV-negative Men Who Have Sex With Men Via Reduction of Social Anxiety and Substance Use in Sexual Situations

This study has finished and is no longer accepting participants.

In Toronto
Anxiety, AddictionBehavioural studyAges 18–65
Countries
Canada
Sponsor
Toronto Metropolitan University
Other study type icon
CompletedNCT05996419

Intervention to Reduce Safety Behaviors

Official study title

Improving Psychosocial Functioning Among Veterans With Social Anxiety: A Pilot Evaluation of Self-Monitoring Intervention to Reduce Safety Behaviors

This study has finished and is no longer accepting participants.

In Charleston
AnxietyInterventional studyAges 18+
Countries
United States
Sponsor
VA Office of Research and Development (Government agency)

Registry coverage

We gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.